MedPath

Preoperative prediction of axillary lymph node burden in early-stage invasive breast cancer

Not Applicable
Completed
Conditions
Early stage breast cancer patients
Cancer
Registration Number
ISRCTN37165899
Lead Sponsor
Chiayi Chang Gung Memorial Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
80
Inclusion Criteria

1. Invasive breast carcinoma confirmed by biopsy
2. Early-stage (clinical stage T1-2)
3. Underwent DCE-MRI examination one week before surgery
4. All patients who received axillary surgery either SLNB or ALND

Exclusion Criteria

1. Non-primary breast cancer or carcinoma in situ-only lesions
2. Excision biopsy before DCE-MRI examination
3. Pre-operative neoadjuvant therapy
4. Incomplete clinical data

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Axillary lymph node burden prediction measured using the model prediction and MRI pathology reports after the axillary surgery at one timepoint
Secondary Outcome Measures
NameTimeMethod
Performance comparison measures using the prediction model and by a radiologist after the axillary surgery at one timepoint
© Copyright 2025. All Rights Reserved by MedPath